drugset / Trial / NCT00726895

A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions

NCT00726895

Phase 1 Completed 24 enrolled Mutual Pharmaceutical Company, Inc.
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of this study is to evaluate and compare the dose proportionality of 324 mg Quinine Sulfate capsules following a single oral dose (1 x 324 mg capsules versus 2 x 324 mg capsules) in healthy adult volunteers when administered under fasting conditions.

Timeline

Start
2004-05
Primary completion
2004-06
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinine Small molecule 324 mg Oral
Subject Quinine Small molecule 648 mg Oral

Indications

No indication recorded.